$227.08
-5.86-2.52%
Ult. Agg.: Nov 4, 5:30 AM
ResMed (RMD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
ResMed (RMD) ha pubblicato l'ultima previsione il ottobre 29, 2026 per fiscal year 2027. La società ha previsto un utile per azione pari a $12 - $12.25, rispetto a una stima di consenso per l'EPS di $12.1. ResMed ha inoltre previsto ricavi pari a $5.75B - $5.85B per il periodo.
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $2.67 | $2.88 | $2.80 | $2.71 |
| Actual | $2.91 | $2.95 | $2.86 | $2.81 |
| Surprise | +8.99% | +2.43% | +2.14% | +3.69% |
| Revenue | ||||
| Estimate | $1.39B | $1.46B | $1.42B | $1.39B |
| Actual | $1.42B | $1.46B | $1.43B | $1.42B |
| Surprise | +1.64% | +0.09% | +0.67% | +2.00% |
| Metric | Q2 '27E | Q3 '27E | Q4 '27E | Q1 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.99 | $3.08 | $3.22 | $3.04 |
| Revenue | ||||
| Consensus | $1.46B | $1.46B | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q1 | Oct 29, 2026 | $2.91 | $2.67 | 8.99 % |
| Q4 | Aug 6, 2026 | $2.95 | $2.88 | 2.43 % |
| Q3 | Apr 30, 2026 | $2.86 | $2.80 | 2.14 % |
| Q2 | Jan 29, 2026 | $2.81 | $2.71 | 3.69 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q1 | Oct 29, 2026 | $1.42B | $1.39B | 1.64 % |
| Q4 | Aug 6, 2026 | $1.46B | $1.46B | 0.09 % |
| Q3 | Apr 30, 2026 | $1.43B | $1.42B | 0.67 % |
| Q2 | Jan 29, 2026 | $1.42B | $1.39B | 2.00 % |